Is fondaparinux safer than enoxaparin for patients undergoing percutaneous coronary intervention?

被引：0
|
作者：
Elliott M Antman
机构：
[1] EM Antman is the Director of the Samuel A Levine Cardiac Unit at the Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School,
[2] Boston,undefined
[3] MA,undefined
[4] USA.,undefined
来源：
Nature Clinical Practice Cardiovascular Medicine | 2008年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：184 / 185
页数：1
相关论文
共 50 条
  • [31] Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention
    Galli, Mattia
    Laborante, Renzo
    Andreotti, Felicita
    Vergallo, Rocco
    Montone, Rocco Antonio
    Iaconelli, Antonio
    Trani, Carlo
    Burzotta, Francesco
    Crea, Filippo
    D'Amario, Domenico
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (08)
  • [32] Antithrombotic therapy in patients undergoing percutaneous coronary intervention
    Popma, JJ
    Ohman, EM
    Weitz, J
    Lincoff, M
    Harrington, RA
    Berger, P
    [J]. CHEST, 2001, 119 (01) : 321S - 336S
  • [33] Bleeding in patients Undergoing Percutaneous Coronary Intervention (PCI)
    Wajih-ur-Rehman
    Hameed, Shahid
    Naveed, Tahir
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (05) : 958 - 962
  • [34] The role of eptifibatide in patients undergoing percutaneous coronary intervention
    Zeymer, Uwe
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (08) : 1147 - 1154
  • [35] Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
    Tsoulou, Vasiliki
    Vasilopoulos, Georgios
    Kapadochos, Theodore
    Pavlatou, Niki
    Kalogianni, Antonia
    Toulia, Georgia
    Dousis, Evangellos
    Panoutsopoulos, George
    Kourakos, Michael
    Polikandrioti, Maria
    [J]. CLINICS AND PRACTICE, 2023, 13 (03) : 621 - 637
  • [36] IS THERE NEPHROPROTECTION FOR PATIENTS ON STATINS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION?
    Ivanova, V.
    Spotti, J.
    Vido, D. A.
    Lasorda, D. M.
    Biederman, R. W.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 112 - 112
  • [37] Fondaparinux results in less bleeding than enoxaparin, irrespective of heparin use, for patients with acute coronary syndromes
    Granger, C. B.
    Wallentin, L.
    Avezum, A.
    Mehta, S.
    Diaz, R.
    Ruda, M.
    Afzal, R.
    Yusuf, S.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 448 - 448
  • [38] Anti-xa activity and outcomes in patients undergoing elective percutaneous coronary intervention with intravenous enoxaparin: The STEEPLE trial
    Montalescot, G
    Steinhubl, S
    Cohen, M
    Desmet, W
    Macaya, C
    White, H
    Gallo, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 36B - 36B
  • [39] Fondaparinux During Intra-Aortic Balloon Pump Counterpulsation in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
    De Luca, Leonardo
    Uguccioni, Massimo
    Putini, Rita Lucia
    Natale, Enrico
    Terranova, Antonio
    Pugliese, Marco
    Biffani, Elisabetta
    De Lio, Lucia
    Piazza, Vito
    Musumeci, Francesco
    [J]. HEART LUNG AND CIRCULATION, 2021, 30 (10): : 1545 - 1551
  • [40] Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
    Graca Santos, L.
    Ribeiro Carvalho, R.
    Montenegro, F.
    Ruivo, C.
    Correia, J.
    Pernencar, S.
    Soares, F.
    Morais, J.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1893 - 1893
12345